Search reports.
Cancer Therapies Market Size, Industry Trends Report | 2031
Get free sample report Request for Customiztion Buy Now

Cancer Therapies Market Size, Industry Trends Report | 2031

Segments - Asia Pacific Cancer Therapies Market by Treatment Types (Chemotherapy, Target Therapy, Immunotherapy, Hormone Therapy, and Other Treatment Types), Cancer Types (Blood Cancer, Breast Cancer, Prostate Cancer, Gastrointestinal Cancer, Gynecologic Cancer, Respiratory/Lung Cancer, and Other Cancer Types), End-users (Hospitals, Specialty Clinics, and Radiation Therapy Centre) and Countries (China, Japan, India, Australia, South Korea, and Rest of Asia Pacific) - Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031

https://growthmarketreports.com/raksha
Author : Raksha Sharma
https://growthmarketreports.com/Vaibhav
Fact-checked by : V. Chandola
https://growthmarketreports.com/Vishal
Editor : Vishal Golekar

Upcoming | Report ID :HC-1513 | 4.6 Rating | 54 Reviews | 187 Pages | Format : PDF Excel PPT

Report Description


The Asia Pacific cancer therapies market size was valued at USD XX Billion in 2022 and is likely to reach USD XX Billion by 2031, expanding at a CAGR of 10.2% during 2023 – 2031. The growth of the market is attributed to the rising cases of people having cancer.

Cancer is a disease characterized by uncontrolled cell proliferation. It is one of the world's worst diseases and the second leading cause of death. Cancer is a type of abnormal cell development that can spread to other parts of the body. Humans have been impacted by approximately 100 different forms of cancer.

Asia Pacific Cancer Therapies Market Outlook

According to the American Cancer Society, 4.2 new instances of aggressive cancer were identified in China in 2015. There has been a considerable increase in the number of individuals suffering from various forms of cancer over the previous decade. One of the most significant risk factors for cancer is smoking. The most frequent cancers in China include lung, stomach, colorectum, liver, and esophagus. Population expansion, age, environmental pollution, and bad eating habits are all contributing to an increase in cancer burden and, as a result, cancer treatments.

Targeted therapy is a type of cancer treatment that differs from standard chemotherapy. The medicines used in target treatment operate by focusing on certain genes or proteins found in cancer cells. With the discovery of tumor cell-specific genes, recent advances in biological treatments have broadened the scope of therapeutic targets for cancer treatment. Among many cancer treatments, immunotherapies/biologics are developing as a promising therapy for finding a lasting cure for various cancer types.

  • Increasing support from the government in terms of initiatives and awareness programs regarding the hazardous effects of smoking is anticipated to spur market expansion in the coming years.

  • Expanding patient support programmes is estimated to drive market growth during the forecast period.

  • Treatment side effects and high therapy costs may impede market expansion over the predicted time.

Scope of Asia Pacific Cancer Therapies Market Report

The report on the Asia Pacific cancer therapies market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Asia Pacific Cancer Therapies Market - Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2022

Historic Data

2016–2021

Forecast Period

2023–2031

Segmentation

Treatment Types (Chemotherapy, Target Therapy, Immunotherapy, Hormone Therapy, and Other Treatment Types), Cancer Types (Blood Cancer, Breast Cancer, Prostate Cancer, Gastrointestinal Cancer, Gynecologic Cancer, Respiratory/Lung Cancer, and Other Cancer Types), and End-users (Hospitals, Specialty Clinics, and Radiation Therapy Centre)

Countries Scope

China, Japan, India, Australia, South Korea, and Rest of Asia Pacific

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Amgen, Astra Zeneca, Bayer AG, Johnson & Johnson, and Merck & Co. Inc.

Asia Pacific Cancer Therapies Market Segment Insights

Target therapy segment is projected to account for a key market share

In terms of treatment types, the Asia Pacific cancer therapies market is bifurcated into chemotherapy, target therapy, immunotherapy, hormone therapy, and other treatment types. The target therapy segment is expected to account for a key share of the market during the forecast period owing to its selectivity for cancer cells while avoiding harm to non-target cells. A rise in R&D and the growing occurrence of various forms of cancer throughout the world are two additional significant reasons driving the segment's growth.

Asia Pacific Cancer Therapies Market Treatment Type

Respiratory/Lung cancer segment is expected to register at a rapid pace

On the basis of cancer types, the Asia Pacific cancer therapies market is segregated into blood cancer, breast cancer, prostate cancer, gastrointestinal cancer, gynecologic cancer, respiratory/lung cancer, and other cancer types. The respiratory/lung cancer segment is expected to account for a key share of the market in the coming years due to a surge in the cases of lung cancer in recent times.

Specialty clinics segment is anticipated to register at a rapid CAGR

In terms of end-users, the Asia Pacific cancer therapies market is divided into hospitals, specialty clinics, and radiation therapy centre. The hospitals segment is expected to account for a key share of the market during the forecast period owing to the rising prevalence of cancer cases and availability of hospitals in every place.

Asia Pacific Cancer Therapies Market End User

China is anticipated to dominate the market

On the basis of countries, the Asia Pacific cancer therapies market is classified as China, Japan, India, Australia, South Korea, and Rest of Asia Pacific. The market of China is anticipated to expand at an impressive CAGR during the forecast period. The countries’ market growth can be attributed to changing lifestyles.

Segments

The Asia Pacific cancer therapies market has been segmented on the basis of

Treatment Types

  • Chemotherapy
  • Target Therapy
  • Immunotherapy
  • Hormone Therapy
  • Other Treatment Types

Cancer Types

  • Blood Cancer
  • Breast Cancer
  • Prostate Cancer
  • Gastrointestinal Cancer
  • Gynecologic Cancer
  • Respiratory/Lung Cancer
  • Other Cancer Types

End-users

  • Hospitals
  • Specialty Clinics
  • Radiation Therapy Centre

Countries

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific

Key Players

  • Amgen
  • Astra Zeneca
  • Bayer AG
  • Johnson & Johnson
  • Merck & Co. Inc.

Competitive Landscape

Key players competing in the Asia Pacific cancer therapies market include Amgen, Astra Zeneca, Bayer AG, Johnson & Johnson, and Merck & Co. Inc. Some of these players are investing in several market strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to increase their market shares.

Asia Pacific Cancer Therapies Market Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Cancer Therapies Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Cancer Therapies Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Cancer Therapies Market - Supply Chain
  4.5. Global Cancer Therapies Market Forecast
     4.5.1. Cancer Therapies Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Cancer Therapies Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Cancer Therapies Market Absolute $ Opportunity
5. Global Cancer Therapies Market Analysis and Forecast by Types
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Types
     5.2.2. Y-o-Y Growth Projections by Types
  5.3. Cancer Therapies Market Size and Volume Forecast by Types
     5.3.1. Chemotherapy
     5.3.2. Target Therapy
     5.3.3. Immunotherapy
     5.3.4. Hormone Therapy
     5.3.5. Other Treatment Types
  5.4. Absolute $ Opportunity Assessment by Types
  5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Cancer Therapies Market Analysis and Forecast by Region
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Region
     6.2.2. Y-o-Y Growth Projections by Region
  6.3. Cancer Therapies Market Size and Volume Forecast by Region
     6.3.1. North America
     6.3.2. Latin America
     6.3.3. Europe
     6.3.4. Asia Pacific
     6.3.5. Middle East and Africa (MEA)
  6.4. Absolute $ Opportunity Assessment by Region
  6.5. Market Attractiveness/Growth Potential Analysis by Region
  6.6. Global Cancer Therapies Demand Share Forecast, 2019-2026
7. North America Cancer Therapies Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
  7.2. North America Cancer Therapies Market Size and Volume Forecast by Country
     7.2.1. U.S.
     7.2.2. Canada
  7.3. Absolute $ Opportunity Assessment by Country
  7.4. North America Cancer Therapies Market Size and Volume Forecast by Types
     7.4.1. Chemotherapy
     7.4.2. Target Therapy
     7.4.3. Immunotherapy
     7.4.4. Hormone Therapy
     7.4.5. Other Treatment Types
  7.5. Basis Point Share (BPS) Analysis by Types
  7.6. Y-o-Y Growth Projections by Types
  7.7. Market Attractiveness/Growth Potential Analysis
     7.7.1. By Country
     7.7.2. By Product Type
     7.7.3. By Application
  7.8. North America Cancer Therapies Demand Share Forecast, 2019-2026
8. Latin America Cancer Therapies Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Latin America Average Pricing Analysis
  8.2. Latin America Cancer Therapies Market Size and Volume Forecast by Country
      8.2.1. Brazil
      8.2.2. Mexico
      8.2.3. Rest of Latin America
   8.3. Absolute $ Opportunity Assessment by Country
  8.4. Latin America Cancer Therapies Market Size and Volume Forecast by Types
     8.4.1. Chemotherapy
     8.4.2. Target Therapy
     8.4.3. Immunotherapy
     8.4.4. Hormone Therapy
     8.4.5. Other Treatment Types
  8.5. Basis Point Share (BPS) Analysis by Types
  8.6. Y-o-Y Growth Projections by Types
  8.7. Market Attractiveness/Growth Potential Analysis
     8.7.1. By Country
     8.7.2. By Product Type
     8.7.3. By Application
  8.8. Latin America Cancer Therapies Demand Share Forecast, 2019-2026
9. Europe Cancer Therapies Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Europe Average Pricing Analysis
  9.2. Europe Cancer Therapies Market Size and Volume Forecast by Country
     9.2.1. Germany
     9.2.2. France
     9.2.3. Italy
     9.2.4. U.K.
     9.2.5. Spain
     9.2.6. Russia
     9.2.7. Rest of Europe
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Europe Cancer Therapies Market Size and Volume Forecast by Types
     9.4.1. Chemotherapy
     9.4.2. Target Therapy
     9.4.3. Immunotherapy
     9.4.4. Hormone Therapy
     9.4.5. Other Treatment Types
  9.5. Basis Point Share (BPS) Analysis by Types
  9.6. Y-o-Y Growth Projections by Types
  9.7. Market Attractiveness/Growth Potential Analysis
     9.7.1. By Country
     9.7.2. By Product Type
     9.7.3. By Application
  9.8. Europe Cancer Therapies Demand Share Forecast, 2019-2026
10. Asia Pacific Cancer Therapies Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Asia Pacific Average Pricing Analysis
  10.2. Asia Pacific Cancer Therapies Market Size and Volume Forecast by Country
     10.2.1. China
     10.2.2. Japan
     10.2.3. South Korea
     10.2.4. India
     10.2.5. Australia
     10.2.6. Rest of Asia Pacific (APAC)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Asia Pacific Cancer Therapies Market Size and Volume Forecast by Types
     10.4.1. Chemotherapy
     10.4.2. Target Therapy
     10.4.3. Immunotherapy
     10.4.4. Hormone Therapy
     10.4.5. Other Treatment Types
  10.5. Basis Point Share (BPS) Analysis by Types
  10.6. Y-o-Y Growth Projections by Types
  10.7. Market Attractiveness/Growth Potential Analysis
     10.7.1. By Country
     10.7.2. By Product Type
     10.7.3. By Application
  10.8. Asia Pacific Cancer Therapies Demand Share Forecast, 2019-2026
11. Middle East & Africa Cancer Therapies Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Middle East & Africa Average Pricing Analysis
  11.2. Middle East & Africa Cancer Therapies Market Size and Volume Forecast by Country
     11.2.1. Saudi Arabia
     11.2.2. South Africa
     11.2.3. UAE
     11.2.4. Rest of Middle East & Africa (MEA)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Middle East & Africa Cancer Therapies Market Size and Volume Forecast by Types
     11.4.1. Chemotherapy
     11.4.2. Target Therapy
     11.4.3. Immunotherapy
     11.4.4. Hormone Therapy
     11.4.5. Other Treatment Types
  11.5. Basis Point Share (BPS) Analysis by Types
  11.6. Y-o-Y Growth Projections by Types
  11.7. Market Attractiveness/Growth Potential Analysis
     11.7.1. By Country
     11.7.2. By Product Type
     11.7.3. By Application
  11.8. Middle East & Africa Cancer Therapies Demand Share Forecast, 2019-2026
12. Competition Landscape
  12.1. Global Cancer Therapies Market: Market Share Analysis
  12.2. Cancer Therapies Distributors and Customers
  12.3. Cancer Therapies Market: Competitive Dashboard
  12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     12.4.1. Amgen
     12.4.2. Astra Zeneca
     12.4.3. Bayer AG
     12.4.4. Johnson & Johnson
     12.4.5. Merck & Co. Inc.

Methodology

Our Clients

sinopec
Nestle SA
The John Holland Group
Siemens Healthcare
Pfizer
Deloitte
General Electric
Microsoft